“It doesn’t change anything: Edouard Philippe cash on his physical metamorphosis due to his illness: Current Woman Le MAG

Édouard Philippe served as Emmanuel Macron’s prime minister for much of his first term. The politician has for some time suffered from several autoimmune diseases which cause a change in its appearance. After announcing that he suffered from vitiligo, a disease which causes the appearance of white spots on the skin, Édouard Philippe also announced…

Read More

Abivax: cash flow of 118 million euros, visibility until mid-2024 – 09/07/2023 at 10:01

(AOF) – Abivax today presents its strategy focused on its preparation for the potential commercialization of its lead drug candidate, obefazimod, in the treatment of IBD (Chronic Inflammatory Bowel Diseases). The priority objective is the extension of obefazimod’s intellectual property globally beyond 2035 and until 2039. The company’s available cash flow amounts to 118 million…

Read More

Maat Pharma: 35.1 million euros in cash, visibility until the 2nd quarter of 2024 – 09/07/2023 at 10:10

(AOF) – Maat Pharma announces that as of June 30, 2023, its cash and cash equivalent position amounted to 35.1 million euros, for a second quarter turnover of 0.7 million euros. The biotech specialist in the development of microbiota therapies aimed at improving the survival of cancer patients, estimates that it has sufficient cash flow…

Read More

Biosenic: 520,000 euros in cash, visibility until October 2023 – 09/07/2023 at 10:17 am

(AOF) – BioSenic expects to have sufficient cash flow to achieve its commercial objectives until October 2023. This company specializing in clinical trials in serious autoimmune and inflammatory diseases and cell therapy ended the first half of 2023 with 0.52 million euros in cash and cash equivalents. Its operating loss for the period amounted to…

Read More